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Abstract
Background: Idiopathic arthrofibrosis occurs in 3-4% of patients who undergo total knee arthroplasty (TKA).
However, little is known about the cellular or molecular changes involved in the onset or progression of this
condition. To classify the histomorphologic changes and evaluate potential contributing factors, periarticular tissues
from the knees of patients with arthrofibrosis were analyzed for fibroblast and mast cell proliferation, heterotopic
ossification, cellular apoptosis, hypoxia and oxidative stress.
Results: The arthrofibrotic tissue was composed of dense fibroblastic regions, with limited vascularity along the
outer edges. Within the fibrotic regions, elevated numbers of chymase/fibroblast growth factor (FGF)-expressing
mast cells were observed. In addition, this region contained fibrocartilage and associated heterotopic ossification,
which quantitatively correlated with decreased range of motion (stiffness). Fibrotic, fibrocartilage and ossified
regions contained few terminal dUTP nick end labeling (TUNEL)-positive or apoptotic cells, despite positive
immunostaining for lactate dehydrogenase (LDH)5, a marker of hypoxia, and nitrotyrosine, a marker for protein
nitrosylation. LDH5 and nitrotyrosine were found in the same tissue areas, indicating that hypoxic areas within the
tissue were associated with increased production of reactive oxygen and nitrogen species.
Conclusions: Taken together, we suggest that hypoxia-associated oxidative stress initiates mast cell proliferation
and FGF secretion, spurring fibroblast proliferation and tissue fibrosis. Fibroblasts within this hypoxic environment
undergo metaplastic transformation to fibrocartilage, followed by heterotopic ossification, resulting in increased
joint stiffness. Thus, hypoxia and associated oxidative stress are potential therapeutic targets for fibrosis and
metaplastic progression of idiopathic arthrofibrosis after TKA.
Background
Limited range of motion is a disabling complication of
total knee arthroplasty (TKA) [1-8]. Idiopathic arthrofi-
brosis, clinically defined as abnormal tissue scarring
within the joint, represents the most severe form of stiff-
ness. Even with surgical intervention or revision arthro-
plasty, the formation of dense fibrous tissue and tissue
contractions can recur, leading to increased severity of
the fibrotic condition and eventual disability, with all
the negative psychological and societal implications this
carries [8]. Unfortunately, there is no clear method by
which patients who are at risk of developing arthrofibro-
sis can be identified.
It is known that arthrofibrosis develops in response to
surgical intervention in approximately 3-4% of patients
undergoing TKA, and the resulting pain and loss of
range of motion leads to patient disability. Thus, to have
the possibility of developing a diagnostic test to pre-
screen patients undergoing TKA and/or of implement-
ing postoperative treatments that may improve the
functional outcome, it is important to understand the
pathoetiology behind the condition. In this study, we
aimed to identify the specific factor(s) responsible for
initiating tissue fibrosis, metaplasia and other histologi-
cal changes that occur in arthrofibrosis.
In agreement with other investigators, we have pre-
viously reported the presence of aggressive fibroblast
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fibrotic tissues [6,8-13]. In general, fibrogenesis resulting
from tissue injury is characterized by fibroblast prolifera-
tion, excessive synthesis and accumulation of extracellu-
lar matrix (ECM) components, and reduced ECM
remodeling. The accumulation of unremodeled ECM can
result in impaired blood flow and oxygen delivery to the
tissue, which leads to tissue hypoxia [14-16]. In response
to hypoxia, expression of glycolytic enzymes such as
lactate dehydrogenase (LDH)5, are induced to promote
glycolysis as a source of ATP [17-20]. In turn, tissue
hypoxia stimulates the recruitment of peripheral blood
fibrocytes to the wound site, where microenvironmental
factors have been shown to induce their ‘transdifferentia-
tion’ into other cell types [21-24]. In vitro,d e r m a lf i b r o -
blasts have been shown to transdifferentiate into
chondrocytes in response to a number of local factors
[25,26], such as mechanical stress, growth factors (for
example, transforming growth factor (TGF)-b1, fibroblast
growth factor (FGF)) and hypoxia [17,24,27,28]. All three
factors induce proteoglycan synthesis, which is an essen-
tial component for attachment and transdifferentiation of
fibroblasts into chondrocytes [29,30].
Reactive oxygen and nitrogen species (RONS) produc-
tion in association with hypoxic conditions has been
previously reported [31], and we have reported the
involvement of inflammation and RONS in the develop-
ment of this condition [13]. The production of RONS
has been shown to stimulate degranulation of mast cells,
another cell type involved directly in the development of
other fibrogenic diseases. In fibroproliferative disorders
of the skin and gastrointestinal tract, mast cells undergo
proliferation and activation, and show increased expres-
sion of mast cell-specific chymase [32-35]. Chymase-
expressing mast cells are generally classified as non-
immune mast cells, differentiating them from mast cells
that only express tryptase and that are involved in aller-
gic and parasitic diseases [34]. The release of chymase
results in the cleavage and activation of TGF-b1 [33,35],
which can stimulate fibroblast proliferation, ECM pro-
duction and transdifferentiation of fibrotic tissue to
fibrocartilage [36,37]. The presence of increased mast
cell numbers has also been observed after tissue injury
in patients with fibrodysplasia ossificans progressiva, a
disease marked by heterotopic ossification [38]. Thus,
the potential for an inter-related involvement of
hypoxia, RONS and mast cells in the development of
arthrofibrosis and tissue metaplasia exists.
The current study was undertaken to evaluate and
classify the histomorphologic pathology that charac-
terizes arthrofibrosis, with the expectation that the
results would promote an understanding of the possible
mechanisms behind the fibrosis and metaplastic changes
that occur during disease progression.
Results
Patient cohort information
Tissues were taken from 10 patients diagnosed with idio-
pathic arthrofibrosis. Patient information including age,
sex, body mass index (BMI), years since initial surgery,
pre-existent comorbidities, and functional scores, particu-
larly range of motion (ROM) were obtained from clinical
charts (Table 1). The control group comprised 10 patients
matched for age and BMI (4 men (mean ± SD age 64 ±
1.0 years, BMI 28.4 ± 2.6) and 6 women (age 61 ±
7.0 years, BMI 38.7 ± 0.25)) who were undergoing primary
TKA for treatment of osteoarthritis (OA) (Table 1).
Evaluating the presence of bone within the arthrofibrotic
tissue
Microcomputed tomography (microCT) and 3 D recon-
structions of the tissue scans were used to evaluate the
presence of bone within the arthrofibrotic tissue, and
indicated that all 10 patient tissues contained minera-
l i z e dm a t e r i a lw i t had e n s i t yc o n s i s t e n tw i t ht h a to f
bone. Five of the 10 patient samples had extensive
amounts of bone as measured by bone volume (BV).
Three representative images are shown in Figure 1 for
the OA, low BV and high BV arthrofibrotic groups.
Some bone was detected in the OA tissues, but it was
significantly (P < 0.05) less than that observed in the
low BV group (Figure 1A; n = 10). The low BV group
showed increased but diffuse mineralization (Figure 1B;
n = 5), and the high BV group contained large bone-like
mineralized deposits (Figure 1C to 1C’; n = 5). However,
blindly evaluated radiographs for all patients showed no
evidence of heterotopic ossification (HO), indicating
that the bone identified by microCT was below the reso-
lution of plain radiography.
To evaluate correlations between BV and patient clini-
cal information, we compared patient variables and tis-
s u eB V .T h eo n l ys i g n i f i c a n tc o r r e l a t i o nw a sb e t w e e n
ROM and BV; the closer the ROM was to normal flex-
ion, the lower the amount of BV (Figure 1D). Once the
ROM was restricted to < 50 degrees, BV increased, and
reached a peak at a ROM of ≤ 20 degrees. For subse-
quent analyses, patients were grouped on the basis of
the amount of BV in their tissues.
Morphological and cell survival aspects of arthrofibrotic
tissue
To characterize tissue removed at the time of the revi-
sion surgery, tissue sections were prepared and stained.
Systematic analysis of the tissues and stains by
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gical regions within each sample. These regions (repre-
sentative images shown in Figure 2) were classified as
fibrotic (Figure 2A, D, G), fibrocartilage with calcifica-
tion (Figure 2B, E, H) and vascular (Figure 2C, F, I).
The morphologic features were highlighted by staining
with hematoxylin and eosin to show the distinct charac-
teristics of each region (Figure 2A-C). To evaluate the
proteoglycan content, tissues were stained with alcian
blue. There was increased proteoglycan deposition
within the fibrotic areas and adjacent fibrocartilage
regions (Figure 2A-C, insets). By contrast, very little pro-
teoglycan deposition was observed in the vascular
regions.
The fibrotic regions (Figure 2A) contained the highest
cell density per cubic millimeter compared with the
fibrocartilage with calcification (Figure 2B) and the vas-
cular regions (Figure 2C). Cells within this portion of
the tissue showed the characteristic spindle-shaped mor-
phology. Other distinctive features were the disorganized
nature of the collagen fibers and decreased vascularity.
Adjacent to the fibrotic areas were regions showing
characteristic features of fibrocartilage with calcification
(Figure 2B). The cells in this region had a distinctly
rounded shape surrounded by a clear lacunar space,
similar to mature chondrocytes, and lay adjacent to the
solid dark region of mineralization (confirmed with ali-
zarin red staining, data not shown). Finally, the outer
edges of the arthrofibrotic tissue showed high vascularity
with the presence of both large and small blood vessels
(Figure 2C).
To determine whether increases in fibroblast number
were related to decreased cell turnover, we assessed cell
survival and apoptosis. Cell survival was evaluated by
Bcl-2 immunohistochemistry, and apoptosis was deter-
mined by terminal dUTP nick end labeling (TUNEL)
counterstained with 4’,6-diamidino-2-phenylindole
(DAPI), a nuclear-specific stain, indicating total cell
number. Both the fibrotic and vascular regions showed
increased Bcl-2 staining (Figure 2D-F). The highest
number of apoptotic, TUNEL-positive (green), blue
fluorescent nuclei was observed in the vascular region
(Figure 2I), with a few apoptotic cells in the fibrocartila-
genous regions (Figure 2H) and almost none in the
fibrotic region (Figure 2G).
Involvement of hypoxia in tissue metaplasia
Given the predominantly low vascularized nature of the
fibrotic and fibrocartilage regions of the arthrofibrotic
tissue and the lack of apoptotic cells, we evaluated the
role of hypoxia and anaerobic glycolysis in cell survival.
To evaluate the hypoxic status and glycolytic index of
the arthrofibrotic tissue, we measured the levels of
LDH5 by immunohistochemistry. We found that LDH5
was strongly expressed in the avascular periarticular
fibrous and fibrocartilage tissue regions (Figure 3A, B),
which is consistent with the metabolic status of carti-
lage. Area analysis of fibrotic regions indicated that
LDH5 expression level was high, regardless of the
amount of bone present (Figure 3D). No LDH5 was
detected in the vascularized region (Figure 3C) or in the
OA cohort tissues (data not shown).
Involvement of RONS and mast cells in tissue fibrosis and
metaplasia
To assess hypoxia-associated RONS production and the
potential colocalization of the observed protein nitrosy-
lation with mast cells, tissues obtained during primary
TKA surgery (OA tissue) and arthrofibrotic tissues were
subjected to nitrotyrosine and chymase immunohisto-
chemistry. Elevated levels of nitrosylated ECM proteins
were observed in the arthrofibrotic tissues (Figure 4B)
compared with the OA tissues (Figure 4A). In the same
areas, increased numbers of chymase expressing mast
cells were observed (Figure 4C, D). The chymase-posi-
tive mast cells also expressed FGF (Figure 4F), a factor
involved in mediating fibroblast proliferation and
Figure 1 Microcomputed tomography (microCT) analysis of the
periarticular tissue and comparison of bone volume (BV) and
range of motion (ROM). Representative microCT images are shown
for (A) minimal calcification in pre-surgical osteoarthritic tissues (n =
5), (B) low BV group (0.07 ± 0.02 mm
3 of hydroxyapatite; n = 5) and
(C) high BV group (7.4 ± 2.7 mm
3; n = 5). Calcified regions
adjoining the fibrocartilage were confirmed by microCT analysis to
have the appearance and density consistent with newly formed
bone. (D) ROM and BV comparisons; the closer the patient ROM
was to normal flexion, the lower the amount of tissue calcification
or BV. Once the ROM was restricted to < 50 degrees, BV increased,
and reached a peak when ROM was ≤ 20 degrees.
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showed increased mast cell numbers in both the vascu-
lar and fibrotic regions, compared with OA tissues,
whereas fibrocartilage regions had few or no mast cells
(Figure 4E). The increase in mast cell number was
directly related to the increase in BV. The number of
mast cells in tissue from patients with high BV was
almost double that of the low BV group.
Discussion
Our results show a direct correlation between the
amount of bone formed during heterotopic ossification
w i t h i nt h ea r t h r o f i b r o t i ct i s s u ea n dr e s t r i c t e dR O M .
Thus, the extent of the fibrogenic response and meta-
plastic changes directly relate to the degree of joint
immobility and corresponding severity of arthrofibrosis.
In addition, the arthrofibrotic tissue had regions that
were fibrotic or contained fibrocartilage, both of which
were predominantly avascular, with cells expressing
LDH5, a hypoxia-specific gene. Despite the hypoxic
environment, cellular apoptosis was not present. The
fibrotic tissue also contained nitrosylated proteins con-
cordant with elevated numbers of chymase and FGF
producing mast cells, indicative of oxidative stress and
increased fibroproliferative factors driving cell survival
and proliferation. Based on these findings, we believe
that hypoxia, hypoxia-associated oxidative stress, and
mast cells drive the proliferation and survival of fibro-
blasts and their metaplastic conversion to fibrocartilage,
which, through the process of endochondral ossification,
results in heterotopic bone formation (Figure 5). These
findings, together with the ultrastructure of the tissue
divided into morphologically distinct regions of fibrosis,
fibrocartilage and adjacent HO, represent a pathological
Figure 2 Tissue morphology, cell survival and programmed cell death in periarticular tissue. Representative images are shown for (A, D,
G) fibrotic (B, E, H), fibrocartilage with calcification (C, F, I) and vascular regions. Tissues were stained (A-C)with hematoxylin and eosin and
alcian blue (insets enlarged 100%), (D-F) Bcl-2 and terminal dUTP nick end labeling (TUNEL); (G-I) green apoptotic cells and 4’,6-diamidino-2-
phenylindole(DAPI)-stained blue stained nuclei. Scale bar = 100 μm.
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is a schematic showing the normal progression of
wound healing (green arrows) contrasted with the pro-
gression of abnormal healing, fibrosis and metaplastic
changes (red arrows).
In a previous study, Ries et al. [6] reported histologic
evidence of tissue fibrosis, and based on radiography,
HO, in five of six arthrofibrotic knees evaluated. Retro-
spective studies by two other groups also demonstrated
evidence of HO in arthrofibrotic knees, but the conclu-
sions reached about the role of HO in stiffness differed
between the two studies [9,10]. Furia et al. reported that
19 of 70 patients (27%) developed HO, and that 73% of
patients with pre-existing heterotopic bone at other sites
developed HO in the index knee. This group found a
correlation between HO and a limitation of postopera-
tive knee flexion. Furthermore, they suggested that preo-
perative measurement of spinal bone mineral density
(BMD) might identify those with increased lumbar
BMD, who are at risk of developing HO. In a separate
study of 500 patients receiving cemented TKAs, the
overall incidence of HO was reported to be 15% [10].
This group concluded that patients who developed HO
tended to be heavier than average and that there was a
male predilection, but concluded that HO did not
appear to have a major influence on the outcome of
TKA. The discrepancy of these findings may reflect the
use of radiography to identify the presence of HO and
the insensitivity of this approach to identify small
amounts of bone formation, considering the HO
observed in tissues by microCT and the lack of radio-
graphic evidence of HO in the current study.
In the current study, we extended the original clinical
study by Ries et al. [6], and found that the arthrofibrotic
tissues consist of three distinct regions. Two of these
regions were fibrotic, one was a highly vascularized area
around the periphery of the excised tissue, and the
other area contained disorganized matrix and increased
proteoglycan content. The disorganization and increased
proteoglycan content of the arthrofibrotic tissues is
Figure 3 Immunohistochemical stain of arthrofibrotic tissue for lactate dehydrogenase (LDH)5.R e p r e s e n t a t i v eL D H 5
immunohistochemical results are shown for (A) fibrotic regions, (B) fibrocartilage/calcified regions and (C) vascular regions of the tissue. (D)
Image analysis of LDH5 for the low and high bone volume (BV) groups. There was no significant difference between the two groups. The high
magnification insets emphasize the increased LDH5 expression in fibroblasts and chondrocytes. Scale bar = 250 μm.
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fibrotic tissues [39]. Altered synthesis of these macro-
molecules has serious implications for wound healing,
inflammation and fibrosis, as they are involved in regu-
lating numerous biologic processes [40]. Directly contig-
uous to the fibrotic areas was the third region type,
consisting of avascular fibrocartilage, which undergoes
endochondral ossification to form bone. Similar to the
finding of Furia et al., the only significant correlation
observed for the current cohort of patients was between
decreased ROM and increased tissue BV [9].
The exact causes of fibroproliferative diseases (often
defined as a wound-healing response that has gone
unchecked, involving the lung, liver, kidney, skin and
eye) is in many cases unknown [24,39,41]. One of the
key events required for normal wound healing is apop-
tosis, and there is evidence for decreased pro-apoptotic
pathway activation in fibroblasts taken from patients
with pulmonary fibrosis [42]. We also found a low
apoptotic index in the arthrofibrotic tissues in our
study, suggesting that the loss of cell death may be a
contributing factor in the fibrotic outcome for these
patients.
Why arthrofibrosis or excessive scar formation devel-
ops in some patients and not others is at present
unknown. It has been suggested that some patients may
be predisposed to develop arthrofibrosis [6,9]. A study
of patients with systemic sclerosis showed evidence of
epigenetic changes in fibroblasts that may contribute to
their continual activation [43]. In addition, microenvir-
onmental changes, such as oxidative stress and hypoxia,
play a pivotal role in mediating fibroblast proliferation,
metaplasia and disease progression in tissues of patients
with systemic sclerosis or those with Dupuytren’sc o n -
tracture, a fibrotic disorder of the hand [24,39,44]. Based
on the observed increases in LDH activity and an anae-
robic isozyme ratio (anaerobic LDH 4-5 versus aerobic
LDH 1-3 isozyme expression), Ratajczak et al. (2007)
concluded that hypoxia was involved in the pathophy-
siology of this disorder as well [44]. Interestingly, these
two fibrotic disorders (systemic scerosis and Dupuyt-
ren’s contracture) are also known to progress from
tissue fibrosis to fibrocartilage formation and tissue
calcification.
To determine the mechanism involved in the meta-
plastic progression of arthrofibrosis, we evaluated tissue
hypoxia. We observed a decrease in tissue vasculariza-
tion and an increase in LDH5 expression. Expression of
Figure 4 Immunohistochemical stain of arthrofibrotic tissue for
nitrotyrosine, chymase and fibroblast growth factor (FGF).
Representative immunohistochemical results are shown for
nitrotyrosine in (A) osteoarthritis (OA) tissue and (B) arthrofibrotic
tissue, and chymase in (C) OA tissue and (D) arthrofibrotic tissue. (E)
Image analysis of mast cell numbers for the low and high bone
volume (BV) groups, compared with the OA cohort. There was a
significant difference between all three groups (P < 0.05). (F)
Representative immunohistochemical result of FGF expression in
mast cells.
Figure 5 Summary of findings of arthrofibrotic progression.
Green arrows indicate normal healing pathway, red arrows highlight
disease progression pathway. The orange box indicates the etiology
of the oxidative fibrotic transformation process supported by our
previous studies [13]. The purple box indicates the pathology of
metaplastic heterotopic ossification, supported by this study.
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regions of the arthrofibrotic tissue. Thus, the in vivo
presence of LDH5 in fibroblasts and fibrocartilage con-
firms the previous in vitro findings, and suggests that
therapeutic intervention to increase tissue vasculariza-
tion may inhibit the progression of this disease process.
Some patients do show a temporary improvement after
physical manipulation of affected joints, which may
increase blood flow to the region. However, manipula-
tion alone is not sufficient to stop disease progression.
As an alternative approach, low-dose irradiation has
been shown to increase the release of vascular endothe-
lial growth factor by activation of mast cells in an
ischemic animal model, promoting vascular regeneration
[45]. In the present study, we found increased numbers
of mast cells in fibrotic regions of the arthrofibrotic tis-
sue, suggesting that low-dose irradiation may be effec-
tive in treating these patients.
Mast cell proliferation and activation and increased
expression of chymase have also been linked to fibroproli-
ferative diseases, such as systemic sclerosis, a fibrotic dis-
order of connective tissue, and neurogenic bladder fibrosis
[32,33,35]. The presence of chymase, a proteolytic enzyme,
and the cleavage and activation of TGF-b have been asso-
ciated with the development of scleroderma or systemic
sclerosis of the skin [33,35]. The presence of increased
mast cell numbers has also been observed after tissue
injury in patients with fibrodysplasia ossificans progressiva,
a disease marked by heterotopic ossification [38]. All three
of these fibrotic diseases undergo metaplastic changes that
progress to tissue calcification, suggesting an association
between chymase-expressing mast cells and tissue meta-
plasia. The role of RONS in mediating mast cell degranu-
lation is associated with both inflammatory cell and
hypoxia-associated production of RONS [13,31]. More-
over, mast cell degranulation stimulates the hypoxia-asso-
ciated increase in RONS, indicating that mast cells play a
key role in hypoxic responses.
Conclusion
In summary, our data implicates oxidative stress, chy-
mase-expressing mast cells and hypoxia as driving forces
for fibrosis and the metaplastic changes observed. Based
on our findings, we suggest that tissue metaplasia in
arthrofibrosis results from increased inflammatory-asso-
ciated oxidative stress, leading to an accumulation of
mast cells (secreting FGF), driving fibroblast prolifera-
tion and creating avascular regions of hypoxia. Hypoxia
and associated oxidative stress induces the metaplastic
conversion of fibrotic tissue to fibrocartilage, and subse-
quent bone formation by endochondral ossification,
with larger bone fragments indicating a longer duration
of fibrosis. Thus, hypoxia and associated oxidative stress
present potential therapeutic targets for fibrosis and
metaplastic progression of idiopathic arthrofibrosis after
TKA.
Methods
The study was performed in accordance with the insti-
tutional review board guidelines at Rush University
Medical Center and The Rothman Institute of Ortho-
paedics at Thomas Jefferson University, and patients
signed a consent form containing an agreement to
volunteer surgical specimens for research.
Tissue collection
This multi-center study used a standardized tissue
retrieval protocol, allowing collection and analysis of
periarticular knee tissues from patients undergoing revi-
sion arthroplasty for severe pain and stiffness. Diagnosis
of idiopathic arthrofibrosis is based on clinical, radiolo-
gical examination and intraoperative findings [8]. For
these patients, the distinct intraoperative findings are
extensive scar tissue formation that fills the lateral, med-
ial and parapatellar gutters. All of the patients had
undergone previous non-surgical attempts to alleviate
pain and stiffness, including physical therapy. In all
cases, other causes, such as infection or misalignment
were ruled out as a cause of stiffness. Tissue samples
from 10 affected knees of patients with arthrofibrosis
and from 10 patients with osteoarthritis (OA) who were
undergoing primary TKA were retrieved. Based on ear-
lier arthrofibrotic studies by Ries et al., knees that were
revised with only pain without stiffness, or with stiffness
for other reasons, were not included in the arthrofibro-
tic group [6]. Radiographs from all patients were evalu-
ated for heterotopic ossification. Primary surgical tissues
were chosen for comparison with arthrofibrotic tissues,
as OA is a chronic wound environment associated with
inflammation and diffuse fibrosis regions that do not
become extensively fibrotic or undergo metaplastic
changes [46].
Tissue samples were taken from the periarticular area,
which included the suprapatellar, medial gutter, lateral
gutter and infrapatellar regions. The tissue was wrapped
in gauze soaked in sterile saline, and transferred or
shipped overnight on ice to the laboratory for fixation
and detailed analyses. Tissue from each anatomical loca-
tion was cut into pieces 2 × 5 mm in size and, depend-
ing on the amount of available tissue, five pieces of
tissue from one region were placed in a paraffin wax
block. An equal number and distribution of tissue pieces
was used for fibroblast isolation. Any remaining tissue
was flash-frozen in liquid nitrogen and stored at -80C.
MicroCT analysis
Each of the paraffin blocks containing tissue were sub-
jected to microCT analysis (μCT 40; Scanco Basserdorf,
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an energy of 45 kVp, current of 88 μA and a 200-ms
integration time, producing a resolution of 20 μm
3 voxel
size. Each scan comprised a minimum of 500 slices
through the entire paraffin block. To achieve image
noise reduction, a constrained three-dimensional Gaus-
sian filter (sigma 1.2, support 2) was applied. A fixed
global threshold for analysis was chosen, which repre-
sented the transition in X-ray attenuation between
unmineralized tissue (< 225 mg hydroxyapatite/cm
2)
and the forming bone (230-700). Analysis consisted of
defining the outer boundary of the tissue for each
20 μm section in the sample. For consistency, the same
settings and thresholds were used for each analysis, and
applied to every sample in the study. Scout, sagittal and
cross-sectional views were examined for evidence of
mineralization.
Histochemical stains
Tissues were fixed in 4% paraformaldehyde, dehydrated,
embedded in paraffin and sectioned (6 μm). The paraffin
blocks were stored at -20°C, and kept on ice between
sections to allow for sectioning through regions contain-
ing small bone pieces. Paraffin sections were dewaxed,
rehydrated and stained with Harris hematoxylin (catalo-
gue number 245-678; Thermo Fisher Scientific Inc. Wal-
tham, MA USA) and eosin Y (245-827; Thermo Fisher
Scientific Inc.) to determine cellularity, vascularization
and tissue morphology. Tissue calcification was deter-
mined with alizarin red S (130-22-3; Acros Organics,
Morris Plains, NJ, USA). To assess proteoglycan content,
the sections were stained with alcian blue 8GX (vA3157
Sigma Chemical Co., St Louis, MO, USA), and nuclei
were identified with nuclear-fast red (EMD Chemicals;
v6409-77-4). Tissue calcification was determined with
alizarin red S as before. Slides were then mounted (Per-
mount; Thermo Fisher Scientific Inc.) coverslipped, and
evaluated by microscopy.
TUNEL assay
Apoptosis was measured by the TUNEL assay, which
takes advantage of the fact that during apoptosis,
nuclear endonucleases digest genomic DNA into frag-
ments of multiples of approximately 200 bp. To measure
the fragmented DNA, the nucleotide ends were labeled
using a commercial kit (In Situ Cell Death Detection
Kit, Peroxidase diaminobenzidine [POD], 11 684 817
910; Roche Diagnostics, Indianapolis, IN, USA) accord-
ing to the manufacturer’s instructions, and fluorescence
was visualized by microscopy as described below. Nuclei
were stained with 10 μg/ml DAPI (D1306; Invitrogen,
Carlsbad, CA, USA) in phosphate-buffered saline.
DNase I recombinant, grade I (04 536 282 001; Roche
Diagnostic) was used according to the manufacturer’s
instructions to generate TUNEL-positive control
sections.
Immunohistochemistry
Paraffin sections were cut at 6 μm and mounted on slides
(Superfrost/Plus; Thermo Fisher Scientific Inc), which
were placed in an oven at 58°C for 30 min before immu-
nostaining. An automated slide stainer (Benchmark XT;
N750-BMKXT-FS; Ventana Research, Pleasantan, CA,
USA) was used for the immunohistochemical staining
reactions. CC2 antigen (in citrate buffer, pH 6.0) retrieval
was carried out for 36 min. Monoclonal anti-chymase
antibody (CalBiochem, San Diego, CA, USA) was used at
1:200 dilution overnight at 4°C. Rabbit anti-nitrotyrosine
(gift of Harry Ischiropoulos, University of Pennsylvania,
PA, USA) was used at 1:1000 dilution for 1 hr at 37°C.
LDH5 sheep polyclonal antibody (Ab9002-1; Abcam Inc.
Cambridge, MA, USA) and Bcl-2 (C-2; Santa Cruz Bio-
technology, Santa Cruz, CA, USA) were used at 1:50 dilu-
tion for 76 min at room temperature. Basic fibroblast
growth factor (bFGF) antibody (Upstate, Lake Placid,
NY) was used at 1:100 dilution overnight at 4°C. Second-
ary rabbit biotinylated anti-sheep IgG or anti-mouse
(Vector Laboratories Inc., Burlingame, CA, USA) were
used at 1:100 dilution. Antibodies were diluted in anti-
body diluent (DakoCytomation; Dako, Glostrup, Den-
mark). A slide stainer equipped with a diaminobenzidine
(DAB) detection kit (iView; Ventana) was used for immu-
noperoxidase visualization of the targeted antigen. Endo-
genous biotin reactivity in the tissue sections was blocked
(Endogenous Biotin Blocking Kit; Ventana). After com-
pletion of the staining run, the slides were briefly washed
in a mild dishwashing detergent solution (Dawn; The
Procter & Gamble Company, Cincinatti, OH, USA) to
remove the liquid coverslip solution, and processed for
hematoxylin counterstaining using a 1:8 dilution of Gills-
3 hematoxylin solution (Polysciences, Warrington, PA,
USA) for 1 min. Slides were then mounted (Permount;
Thermo Fisher Scientific Inc.) coverslipped, and evalu-
ated by microscopy. Secondary anti-mouse fluorescent
dye (Alexa fluor 448; Invitrogen) was used at 1:200 dilu-
tion, and coverslipped using anti-fade mounting medium
(Vectashield; Vector Laboratories Inc.) with DAPI.
Image acquisition, capture and analysis
For each patient, 2-3 blocks of tissue were sectioned,
and complete images of each section (25-30 individual
images) were acquired at 20× magnification Images
were acquired with a digital-cooled charge-coupled
device (CCD) camera with RGB (red, green, blue) elec-
tronic filter (Retiga EXi QImaging, Burnaby, BC,
Canada) or with an alternative digital camera (RT Color
Spot; Diagnostic Instruments, Sterling Heights, MI,
USA) using a microscope (either Optiphot or E800;
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Page 8 of 10Nikon, Melville, NY, USA). Image quantification was
then performed (Image Pro Plus software; (Media
Cybernetics, Silver Spring, MD, USA), using a custo-
mized macro to count DAB-stained cells and nuclei of
cells stained with hematoxylin. A quantitative value of
the inflammatory response was then presented as the
average percentage of positive cells (DAB) per total cell
number (hematoxylin) normalized to total area. The sec-
tion results for each block from each anatomical site
were averaged, and site differences compared.
Statistical analysis
Differences between groups were analyzed using one-
factor analysis of variance, and were considered signifi-
cant at P < 0.05. All data passed normality and equal
variance tests, and were analyzed using Student t-test
with SPSS software (version-Base 13.0; SPSS Inc.,
Chicago, IL, USA).
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